ResMed Aktie
216,40
EUR
-0,50
EUR
-0,23
%
250,53
USD
-0,27
USD
-0,11
%
Werbung
ResMed Aktie Analyse
| 25.09.17 | ResMed Underweight | Barclays Capital | |
| 07.04.16 | ResMed Underweight | Barclays Capital | |
| 27.01.15 | ResMed Under Perform | Northland Capital |
Werbung
Werbung